Quantitative Systematic Strategies LLC Aerie Pharmaceuticals Inc Transaction History

Quantitative Systematic Strategies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 16, 2021	SELL	$11.32 - $16.63 $215,747 - $316,951	-19,059 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$15.16 - $18.97 $190,409 - $238,263	-12,560 Reduced 39.72%	19,059 $305,000
Q1 2021 May 06, 2021	BUY	$13.12 - $20.9 $142,706 - $227,329	10,877 Added 52.44%	31,619 $565,000
Q4 2020 Feb 09, 2021	BUY	$9.12 - $14.49 $189,167 - $300,551	20,742 New	20,742 $280,000
Q1 2020 May 06, 2020	SELL	$11.84 - $25.52 $208,976 - $450,428	-17,650 Closed	0 $0

Q4 2019 Feb 11, 2020	BUY	$17.72 - $25.1 $312,758 - $443,015	17,650 New	17,650 $427,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.